Parks Associates Announces Its Annual Top Leaders in Technology List for 2025

International research and consulting firm honors top innovators shaping the future of entertainment and streaming, energy, connected health, multifamily and smart spaces, and the connected home and security Parks Associates, a leading research and consulting authority on connected lifestyle technologies and technology solutions for business, today released its2025 Top Leaders in Technology, an annual year-end […]

Palisade Bio Announces Granting of Japanese Patent Covering Composition of Matter for Lead Product Candidate, PALI-2108

(NASDAQ:PALI), PALI-2108 is the first and only PDE4 inhibitor in development targetingthe terminal ileum and colon for treatment of ulcerative colitis (UC) and fibrostenotic Crohn's disease (FSCD) to address significant unmet medical needs Ongoing development of PALI-2108 across FSCD and UC, with Phase 2 IND submission planned for H1 2026 Carlsbad, CA, Dec. 30, 2025

Palisade Bio Announces Granting of Japanese Patent Covering Composition of Matter for Lead Product Candidate, PALI-2108

Palisade Bio Announces Granting of Japanese Patent Covering Composition of Matter for Lead Product Candidate, PALI-2108 GlobeNewswire December 30, 2025 PALI-2108 is the first and only PDE4 inhibitor in development targetingthe terminal ileum and colon for treatment of ulcerative colitis (UC) and fibrostenotic Crohn's disease (FSCD) to address significant unmet medical needs Ongoing development of

NovoTech Patent Firm Attorneys Babak Akhlaghi and Steve Becker Recognized as Super Lawyers

NovoTech Patent Firm proudly announces that two of its distinguished attorneys, Steve Becker and Babak Akhlaghi, have once again been honored with the prestigious Super Lawyers recognition for their exceptional work in intellectual property law. This marks Steve Becker's 17th consecutive year receiving this accolade, a testament to his unwavering commitment to excellence and leadership

374Water Awarded Waste Destruction Services Funding from the State of Minnesota for PFAS Destruction in Biosolids

(NASDAQ:SCWO), Critical Milestone Project with Direct Implications for 2026 Commercial Sales Efforts MORRISVILLE, N.C., Dec. 30, 2025 (GLOBE NEWSWIRE) — 374Water Inc. (NASDAQ: SCWO) (“374Water” or the “Company”), a global leader in organic waste destruction technology and services for the industrial, municipal, and federal markets, today announced it has been awarded a Waste Destruction Services

Global Water Resources Declares Monthly Dividend

(NasdaqGM:GWRS), PHOENIX, Dec. 30, 2025 (GLOBE NEWSWIRE) — Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, has declared under its dividend policy a monthly cash dividend in the amount of $0.02533 per common share (an annual dividend rate of $0.30396 per share). The dividend will be payable on January 30, 2026,

374Water Awarded Waste Destruction Services Funding from the State of Minnesota for PFAS Destruction in Biosolids

374Water Awarded Waste Destruction Services Funding from the State of Minnesota for PFAS Destruction in Biosolids GlobeNewswire December 30, 2025 Critical Milestone Project with Direct Implications for 2026 Commercial Sales Efforts MORRISVILLE, N.C., Dec. 30, 2025 (GLOBE NEWSWIRE) — 374Water Inc. (NASDAQ: SCWO) (“374Water” or the “Company”), a global leader in organic waste destruction technology

Global Water Resources Declares Monthly Dividend

Global Water Resources Declares Monthly Dividend GlobeNewswire December 30, 2025 PHOENIX, Dec. 30, 2025 (GLOBE NEWSWIRE) — Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, has declared under its dividend policy a monthly cash dividend in the amount of $0.02533 per common share (an annual dividend rate of $0.30396 per share).

AMTD IDEA Group Achieved 150% Increase in Revenue for First Half in 2025

— AMTD IDEA Group Achieved ~150% Increase in Revenue — Total Net Income Surged 63.7% to US$68.8 million — Hospitality arm's revenue increased by over 60% — Total Assets amounted to US$2.193 billion (US$3.82/share) — Net asset value amounted to US$1,799 million (US$3.13/share) AMTD IDEA Group (“AMTD IDEA” or the “Company”, NYSE: AMTD; SGX: HKB),

IMUNON Announces Pricing of $7.0 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules

(NASDAQ:IMNN), LAWRENCEVILLE, N.J., Dec. 30, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that it has entered into a securities purchase agreement with a single healthcare-focused institutional investor for the purchase and sale of 1,939,114 shares of common stock (or pre-funded warrants

Scroll to Top